Krilac - Thank you for the details. I found myself swamped in information about all the wound care products out there, waded through a few, and then concluded that Excellagen may not be as "singular:" as some appeared to suggest. That said, I would agree that if your description of Excellagen's combined characteristics are essentially unique, Generex should have been focusing more effort and resources on getting that product in the commerce (and revenue!) stream, and not playing with themselves so much on all these other temporary fascinations. That shrieks of questionable management.
Again, thank you for the additional info. I may have been able eventually to get through the information out there, but yours amounted to the "Cliff Notes" version.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links